Tumor suppression in T cell leukemia-The role of Ikaros

Leukemia Research

Volumn 34, Issue 4, 2010, Pages 416-417

  Dovat, Sinisa ^a   Payne, Kimberly J ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CALM AF10; CK2 kinase; Ikaros; Leukemia; Pre B ALL; T ALL

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; NOTCH RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BINDING AFFINITY; CELL CYCLE PROGRESSION; EDITORIAL; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

ANIMALS; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, TUMOR SUPPRESSOR; HUMANS; IKAROS TRANSCRIPTION FACTOR; LEUKEMIA, T-CELL; MICE;

EID: 76749127429     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.10.010     Document Type: Editorial

References (20)

1. Georgopoulos K., Moore D.D., and Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258 5083 (1992) 808-812
2. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79 1 (1994) 143-156
3. Winandy S., Wu P., and Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83 2 (1995) 289-299
4. Kathrein K.L., Lorenz R., Innes A.M., Griffiths E., and Winandy S. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Mol Cell Biol 25 5 (2005) 1645-1654
5. Kathrein K.L., Chari S., and Winandy S. Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line: implications for CD4 regulation. J Biol Chem 283 16 (2008) 10476-10484
6. Dumortier A., Jeannet R., Kirstetter P., Kleinmann E., Sellars M., dos Santos N.R., et al. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 26 1 (2006) 209-220
7. Cobb B.S., Morales-Alcelay S., Kleiger G., Brown K.E., Fisher A.G., and Smale S.T. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 14 (2000) 2146-2160
8. Brown K.E., Guest S.S., Smale S.T., Hahm K., Merkenschlager M., and Fisher A.G. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91 6 (1997) 845-854
9. Dovat S., Ronni T., Russell D., Ferrini R., Cobb B.S., and Smale S.T. A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains. Genes Dev 16 23 (2002) 2985-2990
10. Gomez-del Arco P., Maki K., and Georgopoulos K. Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol 24 7 (2004) 2797-2807
11. Gurel Z., Ronni T., Ho S., Kuchar J., Payne K.J., Turk C.W., et al. Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem 283 13 (2008) 8291-8300
12. Popescu M., Gurel Z., Ronni T., Song C., Hung K.Y., Payne K.J., et al. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem 284 20 (2009) 13869-13880
13. Seldin D.C., and Leder P. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science 267 5199 (1995) 894-897
14. Gomez-del Arco P., Koipally J., and Georgopoulos K. Ikaros SUMOylation: switching out of repression. Mol Cell Biol 25 7 (2005) 2688-2697
15. Greif P.A., Tizazu B., Krause A., Kremmer E., and Bohlander S.K. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 27 20 (2008) 2886-2896
16. Yagi T., Hibi S., Takanashi M., Kano G., Tabata Y., Imamura T., et al. High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis. Blood 99 4 (2002) 1350-1355
17. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446 7137 (2007) 758-764
18. Mullighan C.G., Miller C.B., Radtke I., Phillips L.A., Dalton J., Ma J., et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453 7191 (2008) 110-114
19. Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360 5 (2009) 470-480
20. Marçais A JR, Hernandez L, Soulier J, Sigaux F, Chan S, Kastner P. Genetic inactivation of Ikaros is a rare event in human T-ALL. Leuk Res; in press.